Merit's transradial Prelude sheath:
This article was originally published in Clinica
Executive Summary
The US FDA has given Merit Medical Systems 510(k) market clearance to use its Prelude sheath introducer system in transradial catheterisation applications. "In many European, South American and Asian markets, this access method accounts for the majority of procedures," the South Jordan, Utah firm's chairman and CEO, Fred Lampropoulos, said of the transradial indication.
You may also be interested in...
US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments
FDA’s efforts to tackle misinformation may face fewer legal obstacles moving forward, following oral arguments at the Supreme Court on a case that could have broad ramifications for how the government communicates public health information.
The Dog That Didn’t Bark: ODAC Gives Nod To Three Products Despite Negative FDA Reviews
Oncologic Drugs Advisory Committee was swayed by views of its disease area experts in favorably reporting out Geron’s imetelstat for myelodysplastic syndromes and supplemental applications for the CAR-T products Carvykti and Abecma in earlier lines of multiple myeloma.
Demi Moore’s Wonderbelly Antacid Investment Lands Supporting Role In Her Promotional Posts
Wonderbelly Antacids “free from” ad claims work but failing to disclose Demi Moore is an investor in her promotions doesn’t, NAD says. Dakota Nutrition fails again on NAD’s test of its testing for elderberry in its supplements.